About
Capstan Medical is a medical technology company founded in 2020, based in Santa Cruz, California, with additional offices in Auckland, New Zealand. The company specializes in developing robotic-enabled, minimally invasive solutions for structural heart disease, particularly focusing on heart valve repair and replacement. Led by CEO Maggie Nixon and CTO Dan Wallace, Capstan Medical aims to transform the treatment of heart valve disease by combining surgical robotics with catheter-based technology and next-generation implants. The company has created a robotic platform that integrates heart valve implants with catheter delivery systems, enabling precise valve placement. Capstan Medical has made significant strides in clinical progress, including the successful completion of the world’s first robotic-catheter mitral valve replacements in human patients. With a commitment to addressing unmet clinical needs, particularly for mitral and tricuspid valve diseases, Capstan Medical collaborates with clinical partners globally to advance treatment options and improve patient outcomes.
Technologies
Keywords
Company Information
- Employees68
- Founded2020
- Total Funding$141400000
Location
2801 Mission St, Santa Cruz, California, United States, 95060-5755
